18.01.2015 Views

Gracial ProdMonograph_cover - epgonline.org

Gracial ProdMonograph_cover - epgonline.org

Gracial ProdMonograph_cover - epgonline.org

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Pharmacokinetics<br />

ENG mainly<br />

bound to<br />

albumin and<br />

SHBG<br />

2.2 Ethinylestradiol (EE)<br />

Following oral administration of <strong>Gracial</strong>, ethinylestradiol (EE) is<br />

absorbed within 1.5 hours (Jung-Hoffman et al 1992) and<br />

then distributed throughout the body. The absolute<br />

bioavailability of EE after multiple dosing of a DSG/EE<br />

combination has been calculated as approximately 59% (Back<br />

et al 1987). Plasma EE is 98.5% protein bound, almost<br />

entirely to albumin (Kuhl 1990).<br />

The metabolism of EE involves cytochrome P450-mediated<br />

hydroxylation, with 2-hydroxy-EE and 2-methoxy-EE as the<br />

major metabolites (Purba et al 1987).<br />

Half-life EE<br />

29 hours<br />

EE is eliminated from the body principally as conjugated<br />

metabolites and the elimination half-life has been calculated<br />

at about 29 hours (Bergink et al 1990). Excretion occurs via<br />

urine and feces at a ratio of 1:1.6 (Speck et al 1976).<br />

EE pg/ml)<br />

100<br />

50<br />

Day 7<br />

2 4 6 8 12 24 h<br />

EE (pg/ml)<br />

100<br />

50<br />

Day 22<br />

2 4 6 8 12 24 h<br />

Fig. 5: Ethinylestradiol serum concentration on days<br />

7 and 22 of <strong>Gracial</strong> administration<br />

Jung-Hoffmann et al 1992<br />

8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!